A de novo case of minimal change disease following the first dose of the Moderna mRNA-1273 SARS-CoV-2 vaccine without relapse after the second dose

In recent times, new onset or relapse of nephrotic syndrome following the first dose of SARS-CoV-2 vaccines has been reported. Although the vaccination could trigger nephrotic syndrome, the question of whether the same vaccine should be administered as the second dose remains unanswered. A 25-year-o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mochizuki, Reika Ikegami, Takahashi, Naohiro, Ikenouchi, Ken, Shoda, Wakana, Kuyama, Tamaki, Takahashi, Daiei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014404/
https://www.ncbi.nlm.nih.gov/pubmed/35435622
http://dx.doi.org/10.1007/s13730-022-00702-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014404/
https://www.ncbi.nlm.nih.gov/pubmed/35435622
http://dx.doi.org/10.1007/s13730-022-00702-5

Ejemplares similares